-
1
-
-
79952232216
-
Global Cancer Statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global Cancer Statistics. Ca-a Cancer Journal for Clinicians. 2011; 61(2):69-90.
-
(2011)
Ca-a Cancer Journal for Clinicians
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
84867240781
-
Ovarian cancer: prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report
-
Modugno F and Edwards RP. Ovarian cancer: prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report. Int J Gynecol Cancer. 2012; 22(8):S45-57.
-
(2012)
Int J Gynecol Cancer
, vol.22
, Issue.8
, pp. S45-S57
-
-
Modugno, F.1
Edwards, R.P.2
-
3
-
-
84873040404
-
Resveratrol Exerts Differential Effects in Vitro and in Vivo against Ovarian Cancer Cells
-
Stakleff KS, Sloan T, Blanco D, Marcanthony S, Booth TD and Bishayee A. Resveratrol Exerts Differential Effects in Vitro and in Vivo against Ovarian Cancer Cells. Asian Pacific Journal of Cancer Prevention. 2012; 13:1333-1340
-
(2012)
Asian Pacific Journal of Cancer Prevention
, vol.13
, pp. 1333-1340
-
-
Stakleff, K.S.1
Sloan, T.2
Blanco, D.3
Marcanthony, S.4
Booth, T.D.5
Bishayee, A.6
-
4
-
-
84867044027
-
The future of glioma treatment: stem cells, nanotechnology and personalized medicine
-
Rahman M, Hoh B, Kohler N, Dunbar EM and Murad GJ. The future of glioma treatment: stem cells, nanotechnology and personalized medicine. Future Oncol. 2012; 8(9):1149-1156.
-
(2012)
Future Oncol
, vol.8
, Issue.9
, pp. 1149-1156
-
-
Rahman, M.1
Hoh, B.2
Kohler, N.3
Dunbar, E.M.4
Murad, G.J.5
-
5
-
-
84866980604
-
New therapeutic challenges in advanced bladder cancer
-
Bellmunt J and Petrylak DP. New therapeutic challenges in advanced bladder cancer. Semin Oncol. 2012; 39(5):598-607.
-
(2012)
Semin Oncol
, vol.39
, Issue.5
, pp. 598-607
-
-
Bellmunt, J.1
Petrylak, D.P.2
-
6
-
-
84867688358
-
Moving toward personalized medicine in castration-resistant prostate cancer
-
Van Allen EM and Pomerantz M. Moving toward personalized medicine in castration-resistant prostate cancer. Urol Clin North Am. 2012; 39(4):483-490.
-
(2012)
Urol Clin North Am
, vol.39
, Issue.4
, pp. 483-490
-
-
Van Allen, E.M.1
Pomerantz, M.2
-
7
-
-
84867895902
-
[The change of pathology in the era of personalized medicine using the example of discordant KRAS mutational status in metastasized colorectal carcinoma]
-
Hekeler E, Zoller WG, Wiedorn KH and Bosse A. [The change of pathology in the era of personalized medicine using the example of discordant KRAS mutational status in metastasized colorectal carcinoma]. Dtsch Med Wochenschr. 2012; 137(45):2327-2331.
-
(2012)
Dtsch Med Wochenschr
, vol.137
, Issue.45
, pp. 2327-2331
-
-
Hekeler, E.1
Zoller, W.G.2
Wiedorn, K.H.3
Bosse, A.4
-
8
-
-
79954612742
-
The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer
-
Yang G, Xiao X, Rosen DG, Cheng X, Wu X, Chang B, Liu G, Xue F, Mercado-Uribe I, Chiao P, Du X and Liu J. The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer. Clin Cancer Res. 2011; 17(8):2181-2194.
-
(2011)
Clin Cancer Res
, vol.17
, Issue.8
, pp. 2181-2194
-
-
Yang, G.1
Xiao, X.2
Rosen, D.G.3
Cheng, X.4
Wu, X.5
Chang, B.6
Liu, G.7
Xue, F.8
Mercado-Uribe, I.9
Chiao, P.10
Du, X.11
Liu, J.12
-
9
-
-
79955754016
-
Genomics of the NF-kappa B signaling pathway: hypothesized role in ovarian cancer
-
White KL, Rider DN, Kalli KR, Knutson KL, Jarvik GP and Goode EL. Genomics of the NF-kappa B signaling pathway: hypothesized role in ovarian cancer. Cancer Causes & Control. 2011; 22(5):785-801.
-
(2011)
Cancer Causes & Control
, vol.22
, Issue.5
, pp. 785-801
-
-
White, K.L.1
Rider, D.N.2
Kalli, K.R.3
Knutson, K.L.4
Jarvik, G.P.5
Goode, E.L.6
-
10
-
-
77952808420
-
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer
-
Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC and Annunziata CM. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res. 2010; 70(10):4005-4014.
-
(2010)
Cancer Res
, vol.70
, Issue.10
, pp. 4005-4014
-
-
Hernandez, L.1
Hsu, S.C.2
Davidson, B.3
Birrer, M.J.4
Kohn, E.C.5
Annunziata, C.M.6
-
11
-
-
2542495145
-
Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models
-
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Saito M, Kawagoe J, Takahashi K, Yada-Hashimoto N, Sakata M, Motoyama T, Kurachi H, Tasaka K and Murata Y. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem. 2004; 279(22):23477-23485.
-
(2004)
J Biol Chem
, vol.279
, Issue.22
, pp. 23477-23485
-
-
Mabuchi, S.1
Ohmichi, M.2
Nishio, Y.3
Hayasaka, T.4
Kimura, A.5
Ohta, T.6
Saito, M.7
Kawagoe, J.8
Takahashi, K.9
Yada-Hashimoto, N.10
Sakata, M.11
Motoyama, T.12
Kurachi, H.13
Tasaka, K.14
Murata, Y.15
-
12
-
-
84860641820
-
Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals
-
Chen SS, Michael A and Butler-Manuel SA. Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals. Discov Med. 2012; 13(68):7-17.
-
(2012)
Discov Med
, vol.13
, Issue.68
, pp. 7-17
-
-
Chen, S.S.1
Michael, A.2
Butler-Manuel, S.A.3
-
13
-
-
67349247832
-
TAK1 activation for cytokine synthesis and proliferation of endometriotic cells
-
Taniguchi F, Harada T, Miyakoda H, Iwabe T, Deura I, Tagashira Y, Miyamoto A, Watanabe A, Suou K, Uegaki T and Terakawa N. TAK1 activation for cytokine synthesis and proliferation of endometriotic cells. Mol Cell Endocrinol. 2009; 307(1-2):196-204.
-
(2009)
Mol Cell Endocrinol
, vol.307
, Issue.1-2
, pp. 196-204
-
-
Taniguchi, F.1
Harada, T.2
Miyakoda, H.3
Iwabe, T.4
Deura, I.5
Tagashira, Y.6
Miyamoto, A.7
Watanabe, A.8
Suou, K.9
Uegaki, T.10
Terakawa, N.11
-
14
-
-
76249087046
-
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
-
Inokuchi S, Aoyama T, Miura K, Osterreicher CH, Kodama Y, Miyai K, Akira S, Brenner DA and Seki E. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci U S A. 2010; 107(2):844-849.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.2
, pp. 844-849
-
-
Inokuchi, S.1
Aoyama, T.2
Miura, K.3
Osterreicher, C.H.4
Kodama, Y.5
Miyai, K.6
Akira, S.7
Brenner, D.A.8
Seki, E.9
-
15
-
-
78449312054
-
Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells
-
Omori E, Matsumoto K, Zhu S, Smart RC and Ninomiya-Tsuji J. Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells. Cancer Res. 2010; 70(21):8417-8425.
-
(2010)
Cancer Res
, vol.70
, Issue.21
, pp. 8417-8425
-
-
Omori, E.1
Matsumoto, K.2
Zhu, S.3
Smart, R.C.4
Ninomiya-Tsuji, J.5
-
16
-
-
79961223562
-
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1
-
Melisi D, Xia Q, Paradiso G, Ling J, Moccia T, Carbone C, Budillon A, Abbruzzese JL and Chiao PJ. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. J Natl Cancer Inst. 2011; 103(15):1190-1204.
-
(2011)
J Natl Cancer Inst
, vol.103
, Issue.15
, pp. 1190-1204
-
-
Melisi, D.1
Xia, Q.2
Paradiso, G.3
Ling, J.4
Moccia, T.5
Carbone, C.6
Budillon, A.7
Abbruzzese, J.L.8
Chiao, P.J.9
-
17
-
-
84863419728
-
TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers
-
Singh A, Sweeney MF, Yu M, Burger A, Greninger P, Benes C, Haber DA and Settleman J. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell. 2012; 148(4):639-650.
-
(2012)
Cell
, vol.148
, Issue.4
, pp. 639-650
-
-
Singh, A.1
Sweeney, M.F.2
Yu, M.3
Burger, A.4
Greninger, P.5
Benes, C.6
Haber, D.A.7
Settleman, J.8
-
18
-
-
0034629146
-
TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop
-
Kishimoto K, Matsumoto K and Ninomiya-Tsuji J. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem. 2000; 275(10):7359-7364.
-
(2000)
J Biol Chem
, vol.275
, Issue.10
, pp. 7359-7364
-
-
Kishimoto, K.1
Matsumoto, K.2
Ninomiya-Tsuji, J.3
-
19
-
-
54049157903
-
Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression
-
Yu Y, Ge N, Xie M, Sun W, Burlingame S, Pass AK, Nuchtern JG, Zhang D, Fu S, Schneider MD, Fan J and Yang J. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J Biol Chem. 2008; 283(36):24497-24505.
-
(2008)
J Biol Chem
, vol.283
, Issue.36
, pp. 24497-24505
-
-
Yu, Y.1
Ge, N.2
Xie, M.3
Sun, W.4
Burlingame, S.5
Pass, A.K.6
Nuchtern, J.G.7
Zhang, D.8
Fu, S.9
Schneider, M.D.10
Fan, J.11
Yang, J.12
-
20
-
-
14844295421
-
Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2
-
Singhirunnusorn P, Suzuki S, Kawasaki N, Saiki I and Sakurai H. Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J Biol Chem. 2005; 280(8):7359-7368.
-
(2005)
J Biol Chem
, vol.280
, Issue.8
, pp. 7359-7368
-
-
Singhirunnusorn, P.1
Suzuki, S.2
Kawasaki, N.3
Saiki, I.4
Sakurai, H.5
-
21
-
-
15744392220
-
Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1
-
Kobayashi Y, Mizoguchi T, Take I, Kurihara S, Udagawa N and Takahashi N. Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem. 2005; 280(12):11395-11403.
-
(2005)
J Biol Chem
, vol.280
, Issue.12
, pp. 11395-11403
-
-
Kobayashi, Y.1
Mizoguchi, T.2
Take, I.3
Kurihara, S.4
Udagawa, N.5
Takahashi, N.6
-
22
-
-
80052289019
-
Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-kappa B activation following carrageenan
-
Bhattacharyya S, Borthakur A, Anbazhagan AN, Katyal S, Dudeja PK and Tobacman JK. Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-kappa B activation following carrageenan. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2011; 301(3):G475-G486.
-
(2011)
American Journal of Physiology-Gastrointestinal and Liver Physiology
, vol.301
, Issue.3
, pp. G475-G486
-
-
Bhattacharyya, S.1
Borthakur, A.2
Anbazhagan, A.N.3
Katyal, S.4
Dudeja, P.K.5
Tobacman, J.K.6
-
23
-
-
84874899951
-
H11/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life/Death Decisions and Human Disease
-
395329
-
Aurelian L, Laing JM and Lee KS. H11/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life/Death Decisions and Human Disease. Autoimmune Dis. 2012; 2012:395329.
-
(2012)
Autoimmune Dis
, vol.2012
-
-
Aurelian, L.1
Laing, J.M.2
Lee, K.S.3
-
24
-
-
77956495728
-
Ovarian cancer development and metastasis
-
Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010; 177(3):1053-1064.
-
(2010)
Am J Pathol
, vol.177
, Issue.3
, pp. 1053-1064
-
-
Lengyel, E.1
-
25
-
-
4644315256
-
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion
-
Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD and Hendrix MJ. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol. 2004; 165(4):1087-1095.
-
(2004)
Am J Pathol
, vol.165
, Issue.4
, pp. 1087-1095
-
-
Sood, A.K.1
Coffin, J.E.2
Schneider, G.B.3
Fletcher, M.S.4
DeYoung, B.R.5
Gruman, L.M.6
Gershenson, D.M.7
Schaller, M.D.8
Hendrix, M.J.9
-
26
-
-
80051967783
-
TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells
-
Safina A, Sotomayor P, Limoge M, Morrison C and Bakin AV. TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells. Mol Cancer Res. 2011; 9(8):1042-1053.
-
(2011)
Mol Cancer Res
, vol.9
, Issue.8
, pp. 1042-1053
-
-
Safina, A.1
Sotomayor, P.2
Limoge, M.3
Morrison, C.4
Bakin, A.V.5
-
27
-
-
39749195549
-
TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis
-
Safina A, Ren MQ, Vandette E and Bakin AV. TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis. Oncogene. 2008; 27(9):1198-1207.
-
(2008)
Oncogene
, vol.27
, Issue.9
, pp. 1198-1207
-
-
Safina, A.1
Ren, M.Q.2
Vandette, E.3
Bakin, A.V.4
-
28
-
-
79960352030
-
A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage
-
Yang Y, Xia F, Hermance N, Mabb A, Simonson S, Morrissey S, Gandhi P, Munson M, Miyamoto S and Kelliher MA. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol. 2011; 31(14):2774-2786.
-
(2011)
Mol Cell Biol
, vol.31
, Issue.14
, pp. 2774-2786
-
-
Yang, Y.1
Xia, F.2
Hermance, N.3
Mabb, A.4
Simonson, S.5
Morrissey, S.6
Gandhi, P.7
Munson, M.8
Miyamoto, S.9
Kelliher, M.A.10
-
29
-
-
4344712350
-
TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains
-
Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L and Chen ZJ. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell. 2004; 15(4):535-548.
-
(2004)
Mol Cell
, vol.15
, Issue.4
, pp. 535-548
-
-
Kanayama, A.1
Seth, R.B.2
Sun, L.3
Ea, C.K.4
Hong, M.5
Shaito, A.6
Chiu, Y.H.7
Deng, L.8
Chen, Z.J.9
-
30
-
-
59649116320
-
Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point
-
Liu Q, Busby JC and Molkentin JD. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nat Cell Biol. 2009; 11(2):154-161.
-
(2009)
Nat Cell Biol
, vol.11
, Issue.2
, pp. 154-161
-
-
Liu, Q.1
Busby, J.C.2
Molkentin, J.D.3
-
31
-
-
67349160447
-
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
-
Kleinberg L, Dong HP, Holth A, Risberg B, Trope CG, Nesland JM, Florenes VA and Davidson B. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma. Hum Pathol. 2009; 40(6):795-806.
-
(2009)
Hum Pathol
, vol.40
, Issue.6
, pp. 795-806
-
-
Kleinberg, L.1
Dong, H.P.2
Holth, A.3
Risberg, B.4
Trope, C.G.5
Nesland, J.M.6
Florenes, V.A.7
Davidson, B.8
-
32
-
-
77954297744
-
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
-
Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B and Kohn EC. Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer. Cancer. 2010; 116(13):3276-3284.
-
(2010)
Cancer
, vol.116
, Issue.13
, pp. 3276-3284
-
-
Annunziata, C.M.1
Stavnes, H.T.2
Kleinberg, L.3
Berner, A.4
Hernandez, L.F.5
Birrer, M.J.6
Steinberg, S.M.7
Davidson, B.8
Kohn, E.C.9
-
33
-
-
84858956777
-
NF-kappaB as a target for pancreatic cancer therapy
-
Carbone C and Melisi D. NF-kappaB as a target for pancreatic cancer therapy. Expert Opin Ther Targets. 2012; 16 Suppl 2:S1-10.
-
(2012)
Expert Opin Ther Targets
, vol.16
, pp. S1-S10
-
-
Carbone, C.1
Melisi, D.2
-
34
-
-
79953314461
-
Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
-
Antoon JW, White MD, Slaughter EM, Driver JL, Khalili HS, Elliott S, Smith CD, Burow ME and Beckman BS. Targeting NFkB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biol Ther. 2011; 11(7):678-689.
-
(2011)
Cancer Biol Ther
, vol.11
, Issue.7
, pp. 678-689
-
-
Antoon, J.W.1
White, M.D.2
Slaughter, E.M.3
Driver, J.L.4
Khalili, H.S.5
Elliott, S.6
Smith, C.D.7
Burow, M.E.8
Beckman, B.S.9
-
35
-
-
33845666522
-
TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity
-
Delaney JR and Mlodzik M. TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle. 2006; 5(24):2852-2855.
-
(2006)
Cell Cycle
, vol.5
, Issue.24
, pp. 2852-2855
-
-
Delaney, J.R.1
Mlodzik, M.2
-
36
-
-
65349096856
-
TGF-beta uses the E3-ligase TRAF6 to turn on the kinase TAK1 to kill prostate cancer cells
-
Thakur N, Sorrentino A, Heldin CH and Landstrom M. TGF-beta uses the E3-ligase TRAF6 to turn on the kinase TAK1 to kill prostate cancer cells. Future Oncol. 2009; 5(1):1-3.
-
(2009)
Future Oncol
, vol.5
, Issue.1
, pp. 1-3
-
-
Thakur, N.1
Sorrentino, A.2
Heldin, C.H.3
Landstrom, M.4
-
37
-
-
84861894085
-
Suppression of Tak1 promotes prostate tumorigenesis
-
Wu M, Shi L, Cimic A, Romero L, Sui G, Lees CJ, Cline JM, Seals DF, Sirintrapun JS, McCoy TP, Liu W, Kim JW, Hawkins GA, Peehl DM, Xu J and Cramer SD. Suppression of Tak1 promotes prostate tumorigenesis. Cancer Res. 2012; 72(11):2833-2843.
-
(2012)
Cancer Res
, vol.72
, Issue.11
, pp. 2833-2843
-
-
Wu, M.1
Shi, L.2
Cimic, A.3
Romero, L.4
Sui, G.5
Lees, C.J.6
Cline, J.M.7
Seals, D.F.8
Sirintrapun, J.S.9
McCoy, T.P.10
Liu, W.11
Kim, J.W.12
Hawkins, G.A.13
Peehl, D.M.14
Xu, J.15
Cramer, S.D.16
-
38
-
-
80053320155
-
The MAP3K TAK1: a chock block to liver cancer formation
-
Malato Y and Willenbring H. The MAP3K TAK1: a chock block to liver cancer formation. Hepatology. 2010; 52(4):1506-1509.
-
(2010)
Hepatology
, vol.52
, Issue.4
, pp. 1506-1509
-
-
Malato, Y.1
Willenbring, H.2
-
39
-
-
81255177676
-
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
-
Ahmed N, Zeng M, Sinha I, Polin L, Wei WZ, Rathinam C, Flavell R, Massoumi R and Venuprasad K. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation. Nat Immunol. 2011; 12(12):1176-1183.
-
(2011)
Nat Immunol
, vol.12
, Issue.12
, pp. 1176-1183
-
-
Ahmed, N.1
Zeng, M.2
Sinha, I.3
Polin, L.4
Wei, W.Z.5
Rathinam, C.6
Flavell, R.7
Massoumi, R.8
Venuprasad, K.9
-
40
-
-
84907492857
-
TGF-beta and NF-kappaB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
-
Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z and Van Waes C. TGF-beta and NF-kappaB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2012.
-
(2012)
Oncogene
-
-
Freudlsperger, C.1
Bian, Y.2
Contag Wise, S.3
Burnett, J.4
Coupar, J.5
Yang, X.6
Chen, Z.7
Van Waes, C.8
-
41
-
-
79957480596
-
Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?
-
Vucur M, Roderburg C, Bettermann K, Tacke F, Heikenwalder M, Trautwein C and Luedde T. Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma? Oncotarget. 2010; 1(5):373-378.
-
(2010)
Oncotarget
, vol.1
, Issue.5
, pp. 373-378
-
-
Vucur, M.1
Roderburg, C.2
Bettermann, K.3
Tacke, F.4
Heikenwalder, M.5
Trautwein, C.6
Luedde, T.7
-
42
-
-
84865184231
-
Comparison of tumor grade and stage with nuclear factor kappa b and p38 mitogene activated protein kinase expressions in renal cell cancer
-
Ozbek E, Aliskan T, Otunctemur A, Calik G, Cakir S, Dursun M and Somay A. Comparison of tumor grade and stage with nuclear factor kappa b and p38 mitogene activated protein kinase expressions in renal cell cancer. Archivio italiano di urologia, andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia. 2012; 84(2):53-60.
-
(2012)
Archivio italiano di urologia, andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia
, vol.84
, Issue.2
, pp. 53-60
-
-
Ozbek, E.1
Aliskan, T.2
Otunctemur, A.3
Calik, G.4
Cakir, S.5
Dursun, M.6
Somay, A.7
-
43
-
-
84866731086
-
Targeting of TAK1 in inflammatory disorders and cancer
-
Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci. 2012; 33(10):522-530.
-
(2012)
Trends Pharmacol Sci
, vol.33
, Issue.10
, pp. 522-530
-
-
Sakurai, H.1
-
44
-
-
0032587480
-
Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer
-
McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, Gilmore P and Johnston PG. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. Br J Cancer. 1999; 79(5-6):933-939.
-
(1999)
Br J Cancer
, vol.79
, Issue.5-6
, pp. 933-939
-
-
McDaid, H.M.1
Cairns, M.T.2
Atkinson, R.J.3
McAleer, S.4
Harkin, D.P.5
Gilmore, P.6
Johnston, P.G.7
-
45
-
-
84889594713
-
Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10
-
Al-Alem LF, McCord LA, Southard RC, Kilgore MW and Curry TE, Jr. Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10. Biology of reproduction. 2013; 89(3):73.
-
(2013)
Biology of reproduction
, vol.89
, Issue.3
, pp. 73
-
-
Al-Alem, L.F.1
McCord, L.A.2
Southard, R.C.3
Kilgore, M.W.4
Curry, T.E.5
-
46
-
-
82255186382
-
Cyclic AMP: a selective modulator of NF-kappaB action
-
Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A and Haegeman G. Cyclic AMP: a selective modulator of NF-kappaB action. Cellular and molecular life sciences: CMLS. 2011; 68(23):3823-3841.
-
(2011)
Cellular and molecular life sciences: CMLS
, vol.68
, Issue.23
, pp. 3823-3841
-
-
Gerlo, S.1
Kooijman, R.2
Beck, I.M.3
Kolmus, K.4
Spooren, A.5
Haegeman, G.6
-
47
-
-
77956249593
-
A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling
-
Gao N, Hibi Y, Cueno M, Asamitsu K and Okamoto T. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling. J Biol Chem. 2010; 285(36):28097-28104.
-
(2010)
J Biol Chem
, vol.285
, Issue.36
, pp. 28097-28104
-
-
Gao, N.1
Hibi, Y.2
Cueno, M.3
Asamitsu, K.4
Okamoto, T.5
-
48
-
-
84872012295
-
Increased expression of PITX2 transcription factor contributes to ovarian cancer progression
-
Fung FK, Chan DW, Liu VW, Leung TH, Cheung AN and Ngan HY. Increased expression of PITX2 transcription factor contributes to ovarian cancer progression. PLoS One. 2012; 7(5):e37076.
-
(2012)
PLoS One
, vol.7
, Issue.5
, pp. e37076
-
-
Fung, F.K.1
Chan, D.W.2
Liu, V.W.3
Leung, T.H.4
Cheung, A.N.5
Ngan, H.Y.6
-
49
-
-
84871438705
-
Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells
-
Chan DW, Hui WW, Cai PC, Liu MX, Yung MM, Mak CS, Leung TH, Chan KK and Ngan HY. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells. PLoS One. 2012; 7(12):e52578.
-
(2012)
PLoS One
, vol.7
, Issue.12
, pp. e52578
-
-
Chan, D.W.1
Hui, W.W.2
Cai, P.C.3
Liu, M.X.4
Yung, M.M.5
Mak, C.S.6
Leung, T.H.7
Chan, K.K.8
Ngan, H.Y.9
-
50
-
-
80051723542
-
Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells
-
Lok GT, Chan DW, Liu VW, Hui WW, Leung TH, Yao KM and Ngan HY. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS One. 2011; 6(8):e23790.
-
(2011)
PLoS One
, vol.6
, Issue.8
, pp. e23790
-
-
Lok, G.T.1
Chan, D.W.2
Liu, V.W.3
Hui, W.W.4
Leung, T.H.5
Yao, K.M.6
Ngan, H.Y.7
|